ArticleFrontiers in public health2025

Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.

Lian Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.